ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicenter, Randomized Study of Rucaparib Versus Chemotherapy in Patients With Relapsed, BRCA Mutant, High Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Rucaparib (Primary) ; Carboplatin; Cisplatin; Gemcitabine; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms ARIEL4
- Sponsors Clovis Oncology
- 12 Sep 2017 Trial design presented at the 42nd European Society for Medical Oncology Congress.
- 30 Aug 2017 According to a Clovis Oncology media release, trial design the study will be presented at European Society for Medical Oncology 2017.
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology